ArticleFrontiers in neurology2022

A preliminary trial of botulinum toxin type A in patients with vestibular migraine: A longitudinal fMRI study.

Sun-Young Oh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.